LATEST ALERTS
A hold has been placed on European novel food assessment after the European Food Safety Authority (EFSA) said it was unable to proceed due to identified knowledge gaps in safety data
Spending on CBD- and cannabis-related lobbying in the US exceeded pre-pandemic numbers, with more than $12m spent during the first quarter of 2022 on issues such as efforts to support patient safety, legalisation and decriminalisation
The US Food and Drug Administration (FDA) has issued warnings to four companies that have sold veterinary products containing CBD
This report offers a comprehensive overview of the current regulatory framework in Paraguay for hemp, CBD and cannabis (medical and recreational) as well as possible upcoming changes
The need to improve sleep is one of the main reasons why US consumers buy CBD, according to CBD-Intel’s latest market research; however, a recent report from a CBD watchdog claims that 60% of the CBD products marketed as sleep aids do not contain the amounts of CBD, cannabinol (CBN) and/or melatonin stated on the product labels
This report sets out to guide you through the legal status and classification of two of the most popular cannabinoids, after CBD and THC, in 50 selected countries
Stay up-to-date with key regulatory news and receive complimentary data on a regular basis.
Submit your access request to explore how it can streamlines access to critical cannabis insights
"*" indicates required fields
